This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yanaka, K. Articles by Heros, R. C. Search for Related Content PubMed PubMed Citation Articles by Yanaka, K. Articles by Heros, R. C.

(Stroke. 1996;27:906-912.)
© 1996 American Heart Association, Inc.

Articles

Optimal Timing of Hemodilution for Brain Protection in a Canine Model of Focal Cerebral Ischemia

Kiyoyuki Yanaka, MD, PhD; Paul J. Camarata, MD; Stephen R. Spellman, BA; Drew E. McDonald, BA Roberto C. Heros, MD

From the Department of Neurosurgery, University of Minnesota Medical School, Minneapolis.

Correspondence to Paul J. Camarata, MD, Department of Neurosurgery, University of Minnesota, Box 96 UMHC, 420 Delaware St SE, Minneapolis, MN 55455. E-mail camarpj@maroon.tc.umn.edu.

Background and Purpose Hemodilution is known to ameliorate the effects of focal ischemia when used shortly after cerebral arterial occlusion; however, it remains to be proved whether hemodilution will be effective when used at more clinically relevant times, ie, with some delay between the onset of ischemia and initiation of therapy.

Methods Thirty-two dogs were selected for inclusion in this study. Cerebral infarction was induced by permanent occlusion of the middle cerebral and the azygos anterior cerebral arteries. The animals were allocated to 1 of 4 groups of eight animals each: arterial occlusion without hemodilution (group 1); hemodilution immediately after occlusion (group 2); hemodilution 3 hours after occlusion (group 3); and hemodilution 6 hours after occlusion (group 4). Isovolemic hemodilution to a hematocrit of 30% was performed. The animals were killed 6 days after induction of ischemia, and the infarct size was determined.

Results Groups 2 and 3 showed significant reduction of infarct size (P<.0001) when compared with group 1. The neurological grade of group 3 on postoperative days 4, 5, and 6 was significantly better than those of groups 1 and 4 (P<.01). Group 4 showed a significant increase in the incidence of hemorrhagic infarction when compared with groups 1 and 2 (P<.01).

Conclusions The current study indicates that hemodilution administered as much as 3 hours after ischemia is effective in reducing infarct size and improving neurological status. When administered 6 hours after ischemia, hemodilution is not helpful and may be harmful.

Key Words: cerebral ischemia, focal • hemodilution • neuroprotection • dogs

This article has been cited by other articles:

				E. Ruttmann, J. Willeit, H. Ulmer, O. Chevtchik, D. Hofer, W. Poewe, G. Laufer, and L. C. Muller Neurological Outcome of Septic Cardioembolic Stroke After Infective Endocarditis Stroke, August 1, 2006; 37(8): 2094 - 2099. [Abstract] [Full Text] [PDF]

				H. M. Homi, H. Yang, R. D. Pearlstein, and H. P. Grocott Hemodilution During Cardiopulmonary Bypass Increases Cerebral Infarct Volume After Middle Cerebral Artery Occlusion in Rats Anesth. Analg., October 1, 2004; 99(4): 974 - 981. [Abstract] [Full Text] [PDF]

				R. C Groom High or low hematocrits during cardiopulmonary bypass for patients undergoing coronary artery bypass graft surgery? An evidence-based approach to the question Perfusion, March 1, 2002; 17(2): 99 - 102. [PDF]

				R. C Groom High or low hematocrits during cardiopulmonary bypass for patients undergoing coronary artery bypass graft surgery? An evidence-based approach to the question Perfusion, September 1, 2001; 16(5): 339 - 343. [PDF]

				L. Belayev, Y. Liu, W. Zhao, R. Busto, and M. D. Ginsberg Human Albumin Therapy of Acute Ischemic Stroke : Marked Neuroprotective Efficacy at Moderate Doses and With a Broad Therapeutic Window Stroke, February 1, 2001; 32(2): 553 - 560. [Abstract] [Full Text] [PDF]

				J. Berrouschot, H. Barthel, J. Koster, S. Hesse, A. Rossler, W. H. Knapp, and D. Schneider Extracorporeal Rheopheresis in the Treatment of Acute Ischemic Stroke : A Randomized Pilot Study Stroke, April 1, 1999; 30(4): 787 - 792. [Abstract] [Full Text] [PDF]

				F. T. Aichner, F. Fazekas, M. Brainin, W. Polz, B. Mamoli, and K. Zeiler Hypervolemic Hemodilution in Acute Ischemic Stroke : The Multicenter Austrian Hemodilution Stroke Trial (MAHST) Stroke, April 1, 1998; 29(4): 743 - 749. [Abstract] [Full Text] [PDF]

				A. Rebel, J. A. Ulatowski, K. Joung, E. Bucci, R. J. Traystman, and R. C. Koehler Regional cerebral blood flow in cats with cross-linked hemoglobin transfusion during focal cerebral ischemia Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H832 - H841. [Abstract] [Full Text] [PDF]